| General Information |
| Organism |
Homo sapiens, human |
| Cell Line Description |
CAL-33 is a human head and neck squamous cell carcinoma cell line established in 1983 by J. Gioanni and colleagues at the Antoine Lacassagne Center. The cell line was derived from a primary tumor surgically resected from a 69-year-old Caucasian male diagnosed with moderately differentiated squamous cell carcinoma of the tongue prior to receiving chemotherapy or radiotherapy. CAL-33 cells exhibit a characteristic polygonal, epithelial-like morphology and grow as a tightly adherent monolayer. In the fields of oncology, pharmacology, and radiobiology, CAL-33 is a globally recognized, preferred model for HPV-negative head and neck squamous cell carcinoma (HNSCC). It is widely used to elucidate the molecular signaling pathways driving oral malignancies, evaluate novel small-molecule chemotherapeutic agents, and investigate genetic markers of radioresistance. |
| Tissue |
Head and Neck; derived from Oral Cavity (Tongue) |
| Cell Type |
Epithelial cell |
| Disease |
Tongue Squamous Cell Carcinoma (HNSCC) |
| Morphology |
Epithelioid / Polygonal; grows as a flat adherent monolayer |
| Gender |
Male |
| Age |
69 years |
| Product Format |
Frozen |
| Growth Mode |
Adherent |
| Biosafety Level |
1 (Biosafety classification aligns with standard international repository guidelines for non-infectious human tumor cell lines) |
| Applications |
1. Direct in vitro modeling of tumor biology in HPV-negative head and neck squamous cell carcinoma (HNSCC); 2. Standardized models in radiation oncology for evaluating mechanisms of radioresistance, DNA double-strand break repair, and cellular senescence; 3. High-throughput preclinical screening of novel chemotherapeutic agents, targeted kinase inhibitors (e.g., EGFR and PI3K/mTOR inhibitors), and immunotherapies; 4. Investigation of mechanisms underlying tumor cell migration, invasion, and extracellular matrix remodeling (mediated by matrix metalloproteinase secretion); 5. Establishment of robust subcutaneous and orthotopic xenograft models of tongue cancer in immunodeficient mice (e.g., nude or SCID mice) |
| Shipped In |
Dry ice |
| Storage Temperature |
−196°C (Liquid nitrogen vapor phase only) |
| Characteristics |
| Tumorigenic |
Yes; highly tumorigenic in athymic nude mice, forming progressively expanding squamous cell carcinomas. |
| Karyotype |
Human hyperdiploid karyotype with approximately 4% polyploidy. Modal chromosome distribution center is 49 (ranges from 45–49). |
| Viral Profile |
Verified negative for EBV, HBV, HCV, HIV-1, HIV-2, HPV (Human Papillomavirus), HTLV-1/2, MLV, and SMRV via PCR-based clearance panels. |
| Microsatellite Status |
Stable (MSS). |
| Growth Kinetics |
Robust adherent expansion; typical population doubling time spans approximately 30 to 43 hours depending on culture passage and density. |
| Mycoplasma Test |
Negative |
| Culture Conditions and Handling |
| Subculturing |
1. Completely remove and discard the used complete culture medium from the culture dish. 2. Gently rinse the cell monolayer with sterile, Ca2+/Mg2+-free PBS to neutralize any residual traces of serum containing active trypsin inhibitors. 3. Add 2.0 to 3.0 mL of pre-warmed 0.25% trypsin-0.53 mM EDTA solution, ensuring the cell layer is completely covered. 4. Incubate at 37°C for 5 to 10 minutes, monitoring closely under an inverted microscope. Note: CAL-33 cells form a highly adherent, tightly packed monolayer; a full 10-minute incubation may be required for the cells to fully round up and detach. 5. Add an equal volume of pre-warmed complete culture medium to rapidly neutralize enzyme activity. 6. Gently pipette the suspension up and down to dissociate the cells, centrifuge at ~125 × g (or 300 × g) for 5 minutes, carefully aspirate the supernatant, gently resuspend the cell pellet in fresh medium, and distribute into new vessels. |
| Medium Renewal |
Every 2 to 3 days (or 2 times per week depending on metabolic density shifts) |
| Subcultivation Ratio |
Split confluent cultures at a standard ratio of 1:3 to 1:5 every 4 to 5 days. |
| Culture Conditions |
Atmosphere: Air, 90%; CO2, 10% (or standard Air, 95%; CO2, 5%); Temperature: 37°C |
| Cryopreservation |
90% Complete culture growth medium + 10% DMSO (or 70% Complete medium + 20% FBS + 10% DMSO) |